Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca’s Evan Lippman takes US role at Merck KGaA

Merck also appoints Allene Diaz to the newly created role of senior VP, head of US oncology

Evan Lippman - Merck EMD SeronoMerck KGaA has announced several senior US appointments at its EMD Serono division.

These include the selection of AstraZeneca's Evan Lippman (pictured) as senior VP of neurodegenerative diseases and rheumatology and the internal promotion of Allene Diaz to the newly created role of senior VP, head of US oncology.

The remaining changes are Rami Levin's promotion to VP of marketing, neurodegenerative diseases and rheumatology and confirmation that Craig Millan will be senior VP and head of EMD Serono's US fertility, metabolic endocrinology and HIV franchise having held the role on a temporary basis until now.

“Their knowledge, experience and global perspective will strengthen EMD Serono as a leader in biopharmaceuticals in the US,” said James Hoyes, president of EMD Serono.

“Furthermore, these appointments underscore our commitment to recruiting top external talent and promoting great talent from within.”

Lippman joins EMD Serono from AstraZeneca (AZ) where he most recently served as executive director of the company's Crestor (rosuvastatin calcium) brand.

Previously, he held several senior roles at AZ including executive director and head of US business development. Lippman has also spent time at Pfizer.

Diaz has been involved in EMD's oncology business in the US since 2008, serving as VP oncology marketing. In addition, she also held the role of acting head, oncology global strategic planning from July 2010 to May 2011. Prior to that she held senior roles at Amylin Pharmacueticals, Biogen Idec and Pfizer.

Levin has spent nearly 15 years at Merck, and most recently served as chair and managing director of Merck AB in Sweden and Iceland. In his new role, he will report directly to Lippman.

Millan has been serving in his newly confirmed position on an 'ad-interim' basis since earlier this year. Prior to this, he was EMD Serono's VP of endocrinology marketing, leading marketing efforts across reproductive health, growth hormone deficiency and HIV-related metabolic disorders.

Before joining Merck, Millan served as VP, commercial at Vertex Pharmaceuticals, and has previous experience in marketing roles at Pfizer.

20th June 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena....
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem....

Infographics